Evaluation of polymerization-dependent changes in color and translucency of resin composites using two formulae
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-09-01
著者
-
Kimura Mikio
Department Of Infectious Diseases And Applied Immunology Institute Of Medical Science The University
-
Powers John
Department Of Restorative Dentistry And Biomaterials Houston Biomaterials Research Center The Univer
-
PARAVINA Rade
Department of Restorative Dentistry and Biomaterials, Houston Biomaterials Research Center, The Univ
-
Paravina Rade
Department Of Restorative Dentistry And Biomaterials Houston Biomaterials Research Center The Univer
-
Kimura Mikio
Department Of Infectious Diseases & Applied Immunology Institute Of Medical Science University O
-
Kimura Mikio
Department Of Restorative Dentistry And Biomaterials Houston Biomaterials Research Center The Univer
-
Kimura Mikio
Department of Chemistry, Faculty of Science and Engineering, Saga University
関連論文
- Effects of specular component and polishing on color of resin composites
- Japanese Clinical Trials with Takeda Acellular Pertussis Vaccine(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- A Trial of Alloreactive T-cell Depletion Using Biotinylated Galactose Oxidase for the Prevention of Acute Graft-versus-Host Diseases
- Trial of Isolation of a Virus from Sera of Patients with Kawasaki Disease
- Polyclonal Increases of Serum Immunoglobulins and Increase of Immunoglobulin-Bearing Peripheral Blood Lymphocytes in Children with Kawasaki Disease
- Bone Marrow Transplantation in Children
- Usefulness of a New DNA Diagnostic Method for Malaria; Microtiter Plate-Hybridization(Abstracts from the Malaria Workshop)
- CASES OF OVALE MALARIA AND MALARIAE MALARIA SUCCESSFULLY TREATED WITH MEFLOQUINE
- Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin
- Aerosol Infection Test for Evaluation of Pertussis Vaccine(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Characterization and Clinical Study on the Acellular Pertussis Vaccine Produced by a Combination of Column Purified Pertussis Toxin and Filamentous Hemagglutinin(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis
- Pertussis Vaccine Acceptance Rates and Incidence of Pertussis in Forty Seven Districts (Prefectures) in Japan Since 1977(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Evaluation of Mumps Antibodies after Measles-Mumps-Rubella (MMR) Vaccines
- Correlation of the Modified Scratch Test with the Radioallergosorbent Test (RAST) in Atopic Children
- Effects and Side Effects of a New Trivalent Combined Measles-Mumps-Rubella (MMR) Vaccine
- Clinical and Bacteriological Profiles of Patients with Typhoid Fever Treated during 1975-1998 in the Tokyo Metropolitan Komagome Hospital
- Enzyme Linked Immunosorbent Assay of Rubella Antibody
- Evaluation of polymerization-dependent changes in color and translucency of resin composites using two formulae
- A rapid, simple and sensitive flow cytometric system for detection of Plasmodium falciparum
- Reports on Cases of Neurological Illnesses Occurring after Administration of Acellular Pertussis Vaccines in Japan(B. Vaccine Schedules: Their Pelationship to Current Epidemiology)(II. The Eradication of Pertussis: Current Unsolved Epidemiologic, Clinical
- Experiences with Acellular Pertussis Vaccine in Japan and Epidemiology of Pertussis
- Epidemiology of Pertussis in Japan(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Bond strength of adhesives to dentin contaminated with smoker's saliva
- Effect of mucoprotein on the bond strength of resin composite to human dentin
- Factors affecting in vitro bond strength of bonding agents to human dentin
- Syntheses and properties of [1,1'-bis(.ALPHA.-aminoisobutyric acid)]gramicidin S and [1-.ALPHA.-aminoisobutyric acid]semigramicidin S.
- Field Trial with a Further Attenuated Live Measles Virus Vaccine
- Complement Requirement of the Neutralizing Antibody Appearing After Immunization with Smallpox Vaccine